Howard Herrmann, MD
Interventional Cardiology · Philadelphia, PANPI 1679503783
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $178,286 of the $258,645 with a category attached, or 68.9%. Medtronic accounts for 88.7% of it on its own, with 16 other manufacturers making up the rest. 2025 is the largest year on record at $90,144, 3.8 times the $23,584 reported in 2019. Among interventional cardiology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 412 payments — averaging $627.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$229K
- Edwards Lifesciences$15K
- Abbott$8K
- Shockwave Medical, Inc$3K
- Biosense Webster, Inc.$1K
- Boston Scientific$357
- plus $1K from 11 others
Across 291 payments — averaging $6957.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Edwards Lifesciences$1.1M
- Medtronic$585K
- Shockwave Medical, Inc$113K
- Abbott$64K
- Boston Scientific$59K
- Bayer$57K
- plus $20K from 1 others
What the payments were for
- Consulting fees$40,00015%
- Speaking & faculty fees$178,28669%
- Grants$890%
- Travel & lodging$27,81611%
- Food & beverage$12,2305%
- Education$2250%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 292 | $229,483 |
| Edwards Lifesciences | 43 | $14,674 |
| Abbott | 32 | $8,472 |
| Shockwave Medical, Inc | 11 | $3,375 |
| Biosense Webster, Inc. | 2 | $1,101 |
| Boston Scientific | 6 | $357 |
| Cathworks, Inc. | 3 | $289 |
| Penumbra, Inc. | 4 | $276 |
| Abiomed | 7 | $264 |
| Inari Medical, Inc. | 1 | $142 |
| Cardinal Health 200 LLC | 3 | $63 |
| W. L. Gore & Associates, Inc. | 2 | $39 |
| Teleflex LLC | 2 | $38 |
| Bard Peripheral Vascular, Inc. | 1 | $25 |
| Heartflow, Inc. | 1 | $18 |
| Stryker | 1 | $16 |
| Terumo Medical Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$166,864
- CoreValve Evolut$34,490
- Resolute$9,031
- MitraClip$4,253
- Vascular Lithotripsy$3,125
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$1,950
- Mitra Clip system$1,725
- TRICLIP$1,315
- RESOLUTE ONYX$1,126
- Carto 3$1,063
- Edwards SAPIEN 3 Transcatheter Heart Valve$791
- MitraClip System$329
- FFRangio$268
- SAPIEN 3 Ultra RESILIA$159
- FLOWTRIEVER CATHETER, S$142
- CT THROMBECTOMY SYSTEM KIT$142
- Sentinel$131
- Indigo System$125
- Impella$116
- APOLLOTM$111
How this compares
$258,645 in reported general payments places this provider in the 95th percentile of 281 interventional cardiology providers in Pennsylvania.
See all interventional cardiology providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 17 | $17,151 |
| Rosuvastatin Calcium | 16 | $345 |
| Metoprolol Succinate | 26 | $316 |
| Furosemide | 12 | $157 |
| Losartan Potassium | 11 | $92 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Philadelphia
- Jon GeorgePhiladelphia$637K
- Sanjog KalraPhiladelphia$444K
- Taisei KobayashiPhiladelphia$384K
- Jay GiriPhiladelphia$157K
- Paul FiorilliPhiladelphia$104K
- Nicholas RuggieroPhiladelphia$74K
- Craig FrankilPhiladelphia$59K
- Michael BodePhiladelphia$58K
- Oleg VishnevskyPhiladelphia$49K
- Ashwin NathanPhiladelphia$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.